Refrigerate for best taste
Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management
GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients Story by: Published Date Story by: Topics covered: Share This: Article Content A new University of California San Diego study offers compelling evidence that GLP-1 receptor agonists the class of drugs behind Ozempic, Wegovy and Mounjaro, for example may do more than regulate blood sugar and weight
When a provider evaluates you for GLP-1 treatment, they often look at: Your current weight and BMI Your weight-loss history and what youve tried before Whether you have diabetes, prediabetes, or insulin resistance Your current medications and medical conditions Your family history and overall risk factors The goal is not just to help you lose weight, but to do it safely and in a way that fits your health profile
The most effective medication alternative, glucagon-like peptide-1 (GLP-1) receptor agonists, help you think about food less, not feel hungry as often, and digest food more slowly